Tran Capital Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-7,912
Closed -$206K 42
2022
Q1
$206K Hold
7,912
0.02% 54
2021
Q4
$225K Hold
7,912
0.02% 50
2021
Q3
$252K Hold
7,912
0.02% 45
2021
Q2
$274K Hold
7,912
0.02% 44
2021
Q1
$233K Sell
7,912
-1,413
-15% -$43.5K 0.02% 45
2020
Q4
$286K Hold
9,325
0.03% 49
2020
Q3
$260K Hold
9,325
0.03% 60
2020
Q2
$200K Sell
9,325
-915,213
-99% -$20.2M 0.02% 63
2020
Q1
$20.7M Buy
924,538
+149,196
+19% +$4.09M 3.02% 12
2019
Q4
$22.8M Sell
775,342
-225,260
-23% -$6.12M 2.64% 17
2019
Q3
$26.6M Buy
1,000,602
+668,947
+202% +$20.1M 3.29% 12
2019
Q2
$11.2M Sell
331,655
-2,849
-0.9% -$92.5K 1.4% 31
2019
Q1
$10.7M Buy
+334,504
New +$10.3M 1.82% 22

Other funds holding ELAN

Tran Capital Management's ELAN Position: Q2 2022 in Review

Tran Capital Management sold out of Elanco Animal Health (ELAN) in Q2 2022, closing a stake of 7,912 shares — an estimated $206K sold.

Tran Capital Management first reported a position in ELAN in Q1 2019 and held it in 13 quarters. The position peaked at $26.6M in Q3 2019. 438 funds tracked by Wall St. Rank hold ELAN as of Q2 2022.

  • Tran Capital Management reported no remaining Elanco Animal Health position as of Q2 2022 after selling out during the quarter.
  • Tran Capital Management sold 7,912 Elanco Animal Health shares in Q2 2022, an estimated $206K.
  • Tran Capital Management first reported a position in Elanco Animal Health in Q1 2019 and held it in 13 quarters.
  • Tran Capital Management's Elanco Animal Health position peaked at $26.6M in Q3 2019.
  • 438 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2022.

Based on Tran Capital Management's 13F filing for Q2 2022, filed 27 Jul 2022.